Moderna stock takes a 20% hit: here’s why - MSN

Moderna Inc (NASDAQ: MRNA) tanked as much as 20% in premarket on Monday after lowering its full-year sales guidance by about $1.0 billion. The biotech giant cited headwinds as it …

20%
OFF

Moderna Stock Takes A 20% Hit: Here’s Why - MSN

2 weeks from now

Moderna Inc (NASDAQ: MRNA) tanked as much as 20% in premarket on Monday after lowering its full-year sales guidance by about $1.0 billion. The biotech giant cited headwinds as it …

msn.com

20%
OFF

Moderna Stock Falls 20% In A Month: Time To Sell Or Hold? - MSN

2 weeks from now

Moderna expects to generate revenues between $2.5 billion and $3.5 billion in 2025. For 2026-2028, management expects sales to witness a CAGR of more than 25%, driven by new …

msn.com

8%
OFF

Moderna Stock Is Having Another Very Bad Day. Here’s Why. - MSN

2 weeks from now

Moderna shares were down another 7.8% Wednesday morning after falling 8% Tuesday, crimping what had been the stock’s best month in years. There was no apparent impetus for the selloff, …

msn.com

21%
OFF

Moderna Crashes 21%. 'No Inflection In Sight' After Guidance

2 weeks from now

1 day ago · Shares of Moderna tumbled in early trading Monday after the vaccine maker predicted a steeper-than-expected sales drop in the new year. Moderna said it expects 2025 revenue to …

yahoo.com

20%
OFF

Moderna Stock Falls 20% In A Month: Time To Sell Or Hold?

2 weeks from now

Oct 16, 2024 · Moderna expects to generate revenues between $2.5 billion and $3.5 billion in 2025. For 2026-2028, management expects sales to witness a CAGR of more than 25%, …

yahoo.com

20%
OFF

Moderna Stock Falls 20% In A Month: Time To Sell Or Hold?

2 weeks from now

Oct 16, 2024 · In the past month, the stock has underperformed the industry’s 2.3% fall, as seen in the chart below. It has also underperformed the sector and the S&P 500. Shares of …

nasdaq.com

96%
OFF

Moderna (MRNA) Stock Sinks As Market Gains: Here's Why

2 weeks from now

Oct 14, 2024 · The most recent trading session ended with Moderna (MRNA) standing at $57.73, reflecting a -0.96% shift from the previouse trading day's closing. This change lagged the S&P …

yahoo.com

20%
OFF

Moderna Stock Dropped 20% Last Week. Is It Worth A Look?

2 weeks from now

Oct 7, 2021 · (2% event probability) Moderna’s stock declined -23% over the last ten trading days (two weeks), compared to the broader market (S&P500) which declined by 1.2%; A change of …

nasdaq.com

14%
OFF

Moderna Stock Surges 14% After Covid Vaccine-Maker Surprises …

2 weeks from now

Feb 22, 2024 · He has an underperform rating on Moderna stock. Moderna Stock: Slow Growth Expected. Moderna reiterated its expectation for at least $4 billion in sales this year, a drop …

investors.com

20%
OFF

Moderna Stock Takes A 20% Hit: Here’s Why - Kalkinemedia.com

2 weeks from now

1 day ago · Moderna Inc (NASDAQ: MRNA) tanked as much as 20% in premarket on Monday after lowering its full-year sales guidance by about $1.0 billion. The biotech giant cited …

kalkinemedia.com

$1
OFF

Why Is Moderna’s Stock Crashing Today? Here’s What We Know - MSN

2 weeks from now

The biotech giant revealed plans to slash its R&D budget by $1.1 billion starting in 2027, reducing annual expenditure from $4.8 billion in 2024 to between $3.6 billion and $3.8 billion by 2027.

msn.com

11%
OFF

Moderna (MRNA) Stock Sinks As Market Gains: Here's Why

2 weeks from now

Oct 14, 2024 · The latest trading day saw Moderna ... Stock Sinks As Market Gains: Here's Why. Zacks Equity Research October 14, 2024. MRNA Quick ... indicating changes of +20.11% and …

zacks.com

$497.49
OFF

Here's Why Moderna's Shares Are Rebounding From Recent Losses

2 weeks from now

Aug 17, 2021 · Here's Why Moderna's Shares Are Rebounding From Recent Losses. by Shanthi Rexaline, Benzinga Editor. August 17, ... Moderna stock hit an all-time high of $497.49 on …

benzinga.com

325%
OFF

After A 325% Rise, Here’s Why Moderna Stock Has Further To Run

2 weeks from now

Aug 6, 2021 · Moderna beat analysts’ expectations for top-line growth in the second quarter and announced a $1 billion stock buyback. According to Investor’s Business Daily Moderna’s $4.35 …

forbes.com

13%
OFF

Why Moderna (MRNA) Stock Price Was Up 13% On Tuesday

2 weeks from now

Jan 3, 2024 · Shares of COVID-19 vaccine maker Moderna MRNA rose 13.1% on Jan 2, after analysts at Oppenheimer recently upgraded the stock’s recommendation to Outperform, with a …

nasdaq.com

96%
OFF

Moderna (MRNA) Stock Sinks As Market Gains: Here's Why - MSN

2 weeks from now

The most recent trading session ended with Moderna (MRNA) standing at $57.73, reflecting a -0.96% shift from the previouse trading day's closing. This change lagged the S&P 500's daily …

msn.com

20%
OFF

Moderna Stock Takes A 20% Hit: Here’s Why - One News Page

2 weeks from now

Moderna Inc (NASDAQ: MRNA) tanked as much as 20% in premarket on Monday after lowering its full-year sales guidance by about $1.0 billion. The biotech giant

onenewspage.com

31%
OFF

Here's Why Moderna Stock Hit An All-Time High Today

2 weeks from now

Jun 29, 2021 · Shares of Moderna (MRNA-2.31%) climbed 5% to a record closing high above $234 on Tuesday, with two positive developments contributing to the biotechnology company's …

fool.com

20%
OFF

سهم موديرنا يهبط 20%.. أسباب التراجع | Invezz AR

2 weeks from now

2 days ago · سهم موديرنا يتراجع بنسبة 20%.. إليكم السبب الهند توقف التجارة مع شركات النفط الروسية بموجب العقوبات ...

invezz.com

$100
OFF

Moderna Stock Gains On More Good News, But Is It A Buy?

2 weeks from now

Sep 9, 2021 · [8/10/21] What Drove Moderna Stock From $100 To Near $500? Moderna stock (NASDAQ: MRNA) has rallied from around $104 per share at the end of 2020, to about $485 …

nasdaq.com

FAQs about Moderna stock takes a 20% hit: here’s why - MSN Coupon?

Why did Moderna stock take a 20% hit?

The post Moderna stock takes a 20% hit: here's why appeared first on Invezz Moderna Inc (NASDAQ: MRNA) tanked as much as 20% in premarket on Monday after lowering its full-year sales guidance by about $1.0 billion. The biotech giant cited headwinds as it revised its outlook to $1.5 billion to $2.5 billion in sales for 2025. ...

Is Moderna stock going down a lot?

Moderna's (NASDAQ: MRNA) sales are slowing down, and Moderna stock is going down -- a lot. The coronavirus vaccine maker's shares plunged 21.2% through 10:20 a.m. ET Monday after it updated investors on its 2024 performance and released new guidance for 2025. ...

Why did Moderna stock tumble in early trading?

Shares of Moderna tumbled in early trading Monday after the vaccine maker predicted a steeper-than-expected sales drop in the new year. Moderna said it expects 2025 revenue to range between $1.5 billion and $2.5 billion after hitting as much as $3.1 billion last year. ...

Should you buy Moderna stock on the weakness?

Moderna generated just over $3.0 billion in revenue in 2024 – a number that represents a massive decline from $6.7 billion in 2023 and $18 billion in 2022. That’s part of the reason why Argus analysts downgraded MRNA shares to “hold” last month. ...

Why did Moderna (mRNA) drop 20% in premarket?

Moderna Inc (NASDAQ: MRNA) tanked as much as 20% in premarket on Monday after lowering its full-year sales guidance by about $1.0 billion. The biotech giant cited headwinds as it revised its outlook to $1.5 billion to $2.5 billion in sales for 2025. Its previous guidance called for up to $3.5 billion in sales this year. ...

Why did Moderna stock fall 52% in 2023?

For perspective, Moderna’s revenue plunged 64% y-o-y to $6.8 billion in 2023 due to lower demand for the Covid-19 vaccine. The company expects its sales to fall to around $3.5 billion in 2024. The company’s latest RSV vaccine is yet to show promising sales. This has weighed on MRNA stock, down 52% since early 2024. ...